You are here: Industry Insights > COVID-19

News List

Themis Collaborates with ABL Europe contractpharma
May 13, 2020
ABL will manufacture Themis’ SARS-CoV-2 vaccine candidate in France.
Cipla enters into a licensing agreement With Gilead to expand access to COVID-19 treatment expresspharma
May 13, 2020
As part of the agreement, Cipla will be permitted to manufacture the API and Finished product, and market it in 127 countries including India and South Africa under Cipla’s own brand name.
Jubilant Life Sciences and Gilead sign agreement for Remdesivir expresspharma
May 13, 2020
Jubilant will now have the right to receive a technology transfer of the Gilead manufacturing process to scale up production to enable expedited access of the medicine to COVID-19 patients upon approvals by regulatory authorities in respective countries.
Singota Solutions Collaborates with Noveome Biotherapeutics contractpharma
May 13, 2020
To manufacture therapy to treat severe condition in people infected with COVID-19.
COVID-19 puts public health gaps in focus NMPA
May 12, 2020
Nation plans to address weaknesses identified in response to epidemic.
Latest developments in epidemic control on May 12 NMPA
May 12, 2020
The latest developments on COVID-19 in China.
PM faces calls for inquiry into BAME COVID-19 death risk pharmatimes
May 12, 2020
Campaigners are urging the government to investigate the disproportionate impact of coronavirus on people with black, Asian and minority ethnic (BAME) backgrounds.
ZYUS, VIDO-InterVac collaborate to develop plant-based vaccine for Covid-19 disease pharmaceutical-business-review
May 12, 2020
ZYUS Life Sciences has collaborated with University of Saskatchewan’s Vaccine and Infectious Disease Organisation-International Vaccine Centre (VIDO-InterVac) for the development of a plant-based vaccine for Covid-19 disease.
Certara and DMTC announce research collaboration to study preventative use of chloroquine in health pharmaceutical-business-review
May 12, 2020
Certara, the global leader in model-informed drug development, and DMTC (formerly the Defence Materials Technology Centre) Ltd, which works to enhance Australia’s defense and medical countermeasure capabilities, have entered into a research collaboration.
OPTI Medical Systems Receives EUA for OPTI SARS-CoV-2 RNA PCR Test Kit for COVID-19 americanpharmaceuticalreview
May 12, 2020
OPTI Medical Systems announced the United States Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the OPTI® SARS-CoV-2 RT-PCR laboratory test kit for the detection of SARS-CoV-2.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page